好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Distal Motor Neuropathy as a Manifestation of Charcot-Marie-Tooth Type 2F: An Exceptional Case in the Dominican Republic
Neuromuscular and Clinical Neurophysiology (EMG)
P2 - Poster Session 2 (11:45 AM-12:45 PM)
9-017
To describe a rare case of Charcot-Marie-Tooth disease type 2F (CMT2F) associated with a pathogenic HSPB1 gene mutation in a Dominican patient, highlighting the clinical presentation, diagnostic challenges, and the importance of genetic testing for peripheral neuropathies in countries with limited access to molecular diagnostics.

Charcot-Marie-Tooth (CMT) disease is a chronic hereditary neuropathy that affects approximately 1 in 2,500 people worldwide, although the true prevalence varies among populations. It is classified into subtypes according to the inheritance pattern and whether demyelinating or axonal involvement predominates.
Type 2 (CMT2) corresponds to the axonal form, usually autosomal dominant, characterized by distal muscle atrophy, progressive weakness, and mild sensory loss. Within this group, CMT2F is associated with mutations in the HSPB1 (Heat Shock Protein Beta-1) gene, which plays a critical role in neuronal cytoskeletal stability and cellular stress response.

In the Dominican Republic, scientific literature on CMT is extremely limited, with no systematic records of incidence or population-based genetic studies. Therefore, this case constitutes a rare and significant finding, contributing to the local understanding of hereditary neuropathies.
Case report of a 38-year-old Dominican patient with distal motor neuropathy. Neurological, electrophysiological, and genetic studies were conducted to determine the etiology. Genetic testing confirmed an HSPB1 mutation consistent with CMT type 2F.
The patient presented with distal muscle weakness, atrophy, and steppage gait. Electrophysiological studies showed distal axonal motor neuropathy, and genetic testing revealed a pathogenic HSPB1 mutation, confirming CMT type 2F. No response to immunoglobulin therapy was observed, supporting a hereditary rather than inflammatory etiology.
This rare case of CMT2F in a Dominican patient underscores the need for genetic testing in unexplained distal neuropathies and contributes to the limited regional data on hereditary neuromuscular disorders.
Authors/Disclosures
Madelein Gomez, MD
PRESENTER 		Dr. Gomez has nothing to disclose.
Minelly Rodriguez Severino, MD, FAAN (Hospital Gautier) Dr. Rodriguez Severino has nothing to disclose.
Luis Tusen, MD Dr. Tusen has nothing to disclose.
Rosa Elba Medina, Sr., MBBS Rosa Elba Medina has nothing to disclose.
Vifranny A. Espaillat Duran, MBBS Dr. Espaillat Duran has nothing to disclose.
Enoch De los Rios, MD Mr. De los Rios has nothing to disclose.
Abigail Jean, MD Dr. Jean has received personal compensation for serving as an employee of Servicio Nacional de Salud .
Genesis L. Mendez, Sr., MD Dr. Mendez has nothing to disclose.
Rosa I. Cheas Guerrero, MD Ms. Cheas Guerrero has nothing to disclose.
Marielba Cáceres Lora Dr. Cáceres Lora has nothing to disclose.
NELCIDY M. MORONTA BAEZ, MD Dr. MORONTA BAEZ has nothing to disclose.
Jirandy J. Perez, MD Dr. Perez has nothing to disclose.
Luis M. Gutierrez Vasquez, MD Dr. Gutierrez Vasquez has nothing to disclose.
Karolin S. Castro, MD Dr. Castro has nothing to disclose.
Axel C. Reyes Mr. Reyes has nothing to disclose.